CELLUVISC

CELLUVISC "5 MG/ML EYE DROPS, SOLUTION" 30 SINGLE-DOSE VIALS OF 0.4 ML"

CELLUVISC "5 MG/ML EYE DROPS, SOLUTION" 30 SINGLE-DOSE VIALS OF 0.4 ML"

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Name
CELLUVISC 5 mg/ml eye drops, solution
Sodium carmellose


What is it and what is it for?
CELLUVISC 5 mg/ml contains carmellose sodium, a substance belonging to a group of medicines called artificial tears.

CELLUVISC 5 mg/ml is a humectant and lubricant for ophthalmic use.
It is useful in mild eye irritation or dryness due to alterations in the stability of the tear film.

Talk to your doctor if you do not feel better or if you feel worse.


What you need to know before taking the medicine
Do not use CELLUVISC 5 mg/ml
If you are allergic (hypersensitive) to carmellose sodium or any of the other ingredients of this medicine (listed in section 6).


Warnings and precautions
Since CELLUVISC 5 mg/ml is a sterile preparation, avoid touching the spout of the single-dose vial.
Once opened, the product must not be reused.
For external use only; prolonged use of products for ocular use, especially if applied to the eyes, may cause sensitization (allergy). In this case, discontinue treatment and consult your doctor.
It is advisable to consult your doctor even if these disorders have occurred in the past.
If irritation, pain, redness, changes in vision, or worsening of vision occurs, discontinue use and consult your doctor.

Children and adolescents
The safety and efficacy of CELLUVISC 5 mg/ml eye drops, solution in children and adolescents have not been established.


Possible side effects
Like all medicines, CELLUVISC 5 mg/ml can cause side effects, although not everybody gets them.

The following side effects may occur with CELLUVISC 5 mg/ml:
Common side effects (occur in 1 to 9 patients in 100): eye irritation including burning and discomfort, eye pain, sticky eyes, visual disturbances.

Post-Marketing Data (frequency cannot be estimated from the available data): The following side effects have been reported since CELLUVISC has been marketed: allergic reactions (including eye allergy), blurred vision, sticky eyes, increased tearing of the eyes, redness of the eyes, damage to the surface of the eye due to the tip of the vial touching the eye during use, feeling of having something foreign in the eye.

These side effects are generally transient. However, if they occur, it is advisable to consult your doctor or pharmacist.

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.

CELLUVISC

CELLUVISC "5 MG/ML EYE DROPS, SOLUTION" 30 SINGLE-DOSE VIALS OF 0.4 ML"

CELLUVISC "5 MG/ML EYE DROPS, SOLUTION" 30 SINGLE-DOSE VIALS OF 0.4 ML"

MINSAN code: 034447045
Previous price: €22,00
Regular price €22,00
Regular price €0,00 Sale price €22,00
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.